(0.07%) 5 473.28 points
(0.11%) 39 156 points
(0.39%) 17 786 points
(0.06%) $80.88
(-3.66%) $2.66
(-0.79%) $2 312.30
(0.16%) $28.92
(3.67%) $1 022.60
(0.27%) $0.936
(0.69%) $10.68
(0.43%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury...
Stats | |
---|---|
今日成交量 | 1.01M |
平均成交量 | 537 493 |
市值 | 18.05M |
EPS | $-0.600 ( Q1 | 2024-05-13 ) |
下一个收益日期 | ( $-0.220 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.520 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00200 (0.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Townsend John | Buy | 228 119 | Stock Options |
2024-04-15 | Jermasek Douglas | Buy | 463 250 | Stock Options |
2024-04-15 | Gupta Pramod | Buy | 463 250 | Stock Options |
2024-04-15 | Gupta Shalabh K. | Buy | 1 319 583 | Stock Options |
2023-09-05 | Laumas Sandeep | Buy | 189 236 | Stock Options |
INSIDER POWER |
---|
99.87 |
Last 57 transactions |
Buy: 72 376 966 | Sell: 337 849 |
音量 相关性
Unicycive Therapeutics, 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Unicycive Therapeutics, 相关性 - 货币/商品
Unicycive Therapeutics, 财务报表
Annual | 2023 |
营收: | $675 000 |
毛利润: | $391 000 (57.93 %) |
EPS: | $-1.240 |
FY | 2023 |
营收: | $675 000 |
毛利润: | $391 000 (57.93 %) |
EPS: | $-1.240 |
FY | 2022 |
营收: | $951 000 |
毛利润: | $944 000 (99.26 %) |
EPS: | $-1.200 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.691 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Unicycive Therapeutics,
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。